ID: ALA3142908

Max Phase: Preclinical

Molecular Formula: C17H24B10N2O5

Molecular Weight: 444.51

Molecule Type: Small molecule

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 444.51

Molecular Weight (Monoisotopic): 446.2616

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Lunato AJ, Wang J, Woollard JE, Anisuzzaman AK, Ji W, Rong FG, Ikeda S, Soloway AH, Eriksson S, Ives DH, Blue TE, Tjarks W..  (1999)  Synthesis of 5-(carboranylalkylmercapto)-2'-deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2.,  42  (17): [PMID:10464024] [10.1021/jm990125i]

Source

Source(1):

• Scientific Literature